Companion Animal Products

Current estimates put the UK cat and dog population at around 14.5 million! In a trend which mirrors the demographic shift in the human population, our pets are living longer, healthier lives through improved nutrition and healthcare. The trend has created a real need for effective and safe treatments for "geriatric" chronic conditions such as osteoarthritis, heart disease, and cancer.

Vetmedica's objective is to "extend the lifespan and enhance the quality of life of companion animals" . With that in mind, the company develops and markets pharmaceuticals specifically targeted at improving the quality of life and longevity for veterinary patients. Particular areas of specialty for the company are osteoarthritis and pain relief (Metacam®), cardiovascular disease (Vetmedin®), and skin disease (Viacutan® & Dermocanis®)

More information available at the Metacam® website www.metacam.co.uk

More information available at the Vetmedin® website www.vetmedin.co.uk